Form 4 for RNAC Cartesian Therapeutics, Inc.
Accepted 2023-01-06 00:00:00 ET · period of report 2023-01-04 · accession 0001453687-23-000032 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-01-06 | 2023-01-04+ | RNAC | TRABER PETER G | Chief Medical Off | S - Sale | $1.13 | -11.6K | 446.1K | -3% | -$13.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-01-05 | S | D | 3,445 | $1.13 | 446,141 | D | — | — | |
| 2 | Common | Common Stock | 2023-01-04 | S | D | 15 | $1.14 | 449,586 | D | — | — | |
| 3 | Common | Common Stock | 2023-01-04 | S | D | 8,164 | $1.13 | 449,601 | D | — | — | |
| 4 | Common | Common Stock | 2023-01-05 | S | D | 20 | $1.11 | 446,121 | D | — | — |